X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (765) 765
animals (499) 499
humans (436) 436
antiprotozoal agents - therapeutic use (358) 358
antiprotozoal agents - pharmacology (294) 294
parasitology (228) 228
female (205) 205
male (187) 187
parasitic diseases (154) 154
antiprotozoal agents - administration & dosage (132) 132
tropical medicine (125) 125
leishmaniasis (121) 121
leishmaniasis, visceral - drug therapy (121) 121
pharmacology & pharmacy (119) 119
antiprotozoal agents - chemistry (113) 113
chemistry, medicinal (109) 109
mice (106) 106
analysis (100) 100
visceral leishmaniasis (100) 100
microbiology (98) 98
in-vitro (94) 94
health aspects (93) 93
infectious diseases (91) 91
treatment outcome (89) 89
parasites (88) 88
adult (87) 87
drugs (85) 85
child (81) 81
antiprotozoal agents - economics (80) 80
adolescent (78) 78
drug resistance (76) 76
chemotherapy (75) 75
research (74) 74
malaria (73) 73
kala-azar (68) 68
biochemistry & molecular biology (67) 67
veterinary sciences (64) 64
antiprotozoal agents (63) 63
care and treatment (63) 63
cattle (63) 63
child, preschool (62) 62
immunology (62) 62
plant extracts - pharmacology (62) 62
public, environmental & occupational health (58) 58
cutaneous leishmaniasis (56) 56
parasitic sensitivity tests (56) 56
efficacy (55) 55
drug therapy (54) 54
leishmania - drug effects (53) 53
leishmaniasis, cutaneous - drug therapy (53) 53
middle aged (53) 53
public health (52) 52
research article (52) 52
arctic medicine. tropical medicine (51) 51
infection (51) 51
inhibitory concentration 50 (51) 51
amphotericin b (50) 50
antiprotozoal agents - adverse effects (49) 49
leishmaniasis - drug therapy (49) 49
vector-borne diseases (49) 49
dose-response relationship, drug (48) 48
infections (48) 48
molecular structure (48) 48
structure-activity relationship (48) 48
amphotericin b - therapeutic use (47) 47
antiprotozoal agents - chemical synthesis (46) 46
antiprotozoal agents - isolation & purification (46) 46
india (46) 46
chemistry, organic (44) 44
diagnosis (43) 43
tropical diseases (43) 43
leishmaniasis, visceral - epidemiology (42) 42
infant (41) 41
leishmania (41) 41
trypanosoma cruzi - drug effects (41) 41
derivatives (40) 40
medicine (40) 40
miltefosine (40) 40
phosphorylcholine - analogs & derivatives (40) 40
plasmodium-falciparum (40) 40
public aspects of medicine (40) 40
physiological aspects (39) 39
biomedicine (38) 38
cancer (38) 38
mice, inbred balb c (38) 38
epidemiology (37) 37
medical microbiology (37) 37
protozoa (37) 37
cytotoxicity (36) 36
antiprotozoal activity (35) 35
sodium stibogluconate (35) 35
cell line (34) 34
chagas-disease (34) 34
drug discovery (34) 34
resistance (34) 34
toxicity (34) 34
article (33) 33
disease models, animal (33) 33
liposomal amphotericin-b (33) 33
antiprotozoal (32) 32
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (812) 812
French (6) 6
Portuguese (3) 3
Dutch (2) 2
Spanish (2) 2
German (1) 1
Norwegian (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, pp. e0172465 - e0172465
Visceral leishmaniasis (VL) is a deadly neglected tropical disease that poses a serious problem in various countries all over the world. Implementation of... 
NETS | IMPACT | PHLEBOTOMUS-ARGENTIPES | BIHAR | MULTIDISCIPLINARY SCIENCES | BIOLOGY | DYNAMICS | STATE | MODEL | CANINE | VECTOR | Drug Costs | Insecticide-Treated Bednets - economics | Leishmaniasis, Visceral - prevention & control | Humans | Leishmaniasis, Visceral - transmission | Antiprotozoal Agents - economics | Insect Bites and Stings - epidemiology | Insecticides - economics | Computer Simulation | Leishmaniasis, Cutaneous - epidemiology | Disease Reservoirs | Psychodidae - parasitology | Seasons | Insect Control - methods | Models, Theoretical | Insect Control - economics | India - epidemiology | Leishmaniasis, Cutaneous - drug therapy | Insect Bites and Stings - parasitology | Animals | Cost-Benefit Analysis | Insect Vectors - parasitology | Leishmania | Antiprotozoal Agents - therapeutic use | Leishmaniasis, Visceral - economics | Leishmaniasis, Visceral - epidemiology | Prevention | Kala-azar | Usage | Control | Care and treatment | Disease transmission | Analysis | Insecticides | Drug resistance | Intervention | Parameter estimation | Laboratories | Chemical engineering | Sprays | Variations | Biting | Infections | Mathematics | Parasites | Tropical diseases | Insecticide resistance | Agrochemicals | Parasitic diseases | Visceral leishmaniasis | Mathematical models | Vector-borne diseases | Fluctuations | Immunization | Sensitivity analysis | Sprayers | Vectors | Leishmaniasis | Disease control | Zoonoses | Studies | Optimal control | Cholera | Control theory | Cost analysis | Bednets | Index Medicus
Journal Article
PLoS neglected tropical diseases, ISSN 1935-2727, 11/2018, Volume 12, Issue 11, pp. e0006809 - e0006809
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 04/2017, Volume 11, Issue 4, pp. e0005459 - e0005459
Background Oral miltefosine has been shown to be non-inferior to first-line, injectable meglumine antimoniate (MA) for the treatment of cutaneous leishmaniasis... 
CLINICAL-TRIAL | EFFICACY | TUBERCULOSIS | SUSCEPTIBILITY | DISEASE | RANDOMIZED CONTROLLED-TRIAL | VISCERAL LEISHMANIASIS | BURDEN | PARASITOLOGY | TROPICAL MEDICINE | TREATMENT FAILURE | CHILDREN | Caregivers | Drug Costs | United States | Humans | Organometallic Compounds - economics | Antiprotozoal Agents - economics | Child, Preschool | Directly Observed Therapy - economics | Male | Phosphorylcholine - analogs & derivatives | Phosphorylcholine - administration & dosage | Leishmaniasis, Cutaneous - economics | Sensitivity and Specificity | Leishmania - drug effects | Female | Phosphorylcholine - economics | Child | Administration, Oral | Meglumine - economics | Treatment Outcome | Leishmaniasis, Cutaneous - drug therapy | Injections, Intramuscular | Meglumine Antimoniate | Cost-Benefit Analysis | Meglumine - administration & dosage | Antiprotozoal Agents - administration & dosage | Monte Carlo Method | Organometallic Compounds - administration & dosage | Care and treatment | Leishmaniasis, Cutaneous | Meglumine antimoniate | Analysis | Economic aspects | Research | Medical care, Cost of | Pediatrics | Costs | Funding | Clinical trials | Tropical diseases | Cutaneous leishmaniasis | Parasitic diseases | Children | Public health | Cost engineering | Medical research | Monte Carlo method | Sensitivity analysis | Computer simulation | Leishmaniasis | Patients | Medicine | Studies | Miltefosine | Travel | Infectious diseases | Internet | Cost analysis | Index Medicus
Journal Article
Journal Article